Transposon Therapeutics Receives Fast Track Designation for PSP Treatment

Graphic: Transposon Therapeutics Receives Fast Track Designation for PSP Treatment

Biotechnology company Transposon Therapeutics announced on May 21 that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for an intervention developed to treat progressive supranuclear palsy (PSP), an FTD disorder that primarily affects movement. The designation was granted to TPN-101, an orally administered drug that targets LINE-1, a virus-like…

Read More

June 24, 2024: VA Caregiver Support Annual Summit

AFTD staff will have an information table during the annual summit of the VA New Jersey Health Care System in East Orange. The event, which this year is titled “Beyond the Caregiving Role: Seeing the ‘Whole’ Caregiver,” will be held in the third floor auditorium in the East Orange VA Medical Center on June 24,…

Read More

VA Caregiver Support Annual Summit

AFTD staff will have an information table during the annual summit of the VA New Jersey Health Care System in East Orange. The event, which this year is titled “Beyond the Caregiving Role: Seeing the ‘Whole’ Caregiver,” is held in the third floor auditorium in the East Orange VA Medical Center.

Read More

Aprinoia Therapeutics Receives Fast Track Designation for PET Tracer for PSP Diagnosis

Graphic: Aprinoia Therapeutics Receives Fast TRack Designation for PET Tracer Used to Diagnose PET

Biopharmaceutical company Aprionoia Therapeutics announced that it has received an FDA Fast Track Designation for an imaging tracer used to diagnose progressive supranuclear palsy (PSP), an FTD disorder that primarily affects movement. Aprinoia is evaluating the safety and efficacy of APN-1607, a PET tracer that can visualize two types of tau protein that contribute to…

Read More

Dear HelpLine – Support for Young Adults

Graphic: Dear HelpLine - Support for Young Adults

Dear HelpLine, My mom was diagnosed with FTD and I’m looking to connect with other young adults caring for a parent with FTD. Without support, I am overwhelmed and feel alone. Do you have any suggestions? Because FTD often occurs at a younger age, young adults in the family regularly find themselves becoming a primary…

Read More

Advancing Hope: AFTD Joins National Institutes of Health AMP ALS Initiative as Partner

Graphic: AFTD Joins National Institutes of Health AMP-ALS Initiative as Partner

AFTD is joining fellow nonprofits, biopharmaceutical companies, and the U.S. Food and Drug Administration (FDA) as partners in the Accelerating Medicines Partnership for ALS (AMP ALS) initiative. AFTD’s participation in the initiative was made possible thanks to the support of David and Weezie Reese. The 2011 discovery that mutations of the gene c9orf72 can cause…

Read More

New York FTD Registry Bill Passes State Senate

A bill establishing a registry of FTD diagnoses in New York State unanimously passed the state Senate on June 5. Sponsored by Sen. Michelle Hinchey, Senate Bill 7874 requires healthcare providers in New York to report diagnoses of FTD to a registry run by the state Department of Health (DOH). The bill also establishes an…

Read More